CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for cancer patients: drug may prevent chemo delays from low platelets
Disease control OngoingThis study tests whether the drug avatrombopag can safely raise low platelet counts caused by chemotherapy in people with gastrointestinal cancers. About 60 adults will receive either avatrombopag or a placebo. The goal is to see if the drug helps patients keep their platelet cou…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New drug could keep chemo on track for cancer patients
Symptom relief OngoingThis study tests a drug called romiplostim in 145 adults with lung, ovarian, or breast cancer who have low platelets from chemotherapy. The goal is to see if it helps them get their full chemo doses on time without delays or reductions. Romiplostim works by boosting platelet prod…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated May 26, 2026 08:32 UTC